DK1484056T3 - Sammensætninger med langsom frigivelse og fremgangsmåde til fremstilling af disse - Google Patents

Sammensætninger med langsom frigivelse og fremgangsmåde til fremstilling af disse

Info

Publication number
DK1484056T3
DK1484056T3 DK03742668.1T DK03742668T DK1484056T3 DK 1484056 T3 DK1484056 T3 DK 1484056T3 DK 03742668 T DK03742668 T DK 03742668T DK 1484056 T3 DK1484056 T3 DK 1484056T3
Authority
DK
Denmark
Prior art keywords
processes
preparation
slow release
release compositions
compositions
Prior art date
Application number
DK03742668.1T
Other languages
English (en)
Inventor
Yuso Tomohira
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK1484056T3 publication Critical patent/DK1484056T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/501Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03742668.1T 2002-02-21 2003-02-20 Sammensætninger med langsom frigivelse og fremgangsmåde til fremstilling af disse DK1484056T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002044460 2002-02-21
PCT/JP2003/001837 WO2003070223A1 (en) 2002-02-21 2003-02-20 Sustained release preparations and process for producing the same

Publications (1)

Publication Number Publication Date
DK1484056T3 true DK1484056T3 (da) 2013-09-08

Family

ID=27750550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03742668.1T DK1484056T3 (da) 2002-02-21 2003-02-20 Sammensætninger med langsom frigivelse og fremgangsmåde til fremstilling af disse

Country Status (13)

Country Link
US (1) US7927628B2 (da)
EP (1) EP1484056B1 (da)
JP (1) JP4355925B2 (da)
KR (1) KR100913281B1 (da)
CN (1) CN1301104C (da)
AU (1) AU2003211243B8 (da)
CA (1) CA2475441C (da)
DK (1) DK1484056T3 (da)
ES (1) ES2429436T3 (da)
MX (1) MXPA04008137A (da)
PT (1) PT1484056E (da)
TW (1) TWI286481B (da)
WO (1) WO2003070223A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8734843B2 (en) * 2003-06-27 2014-05-27 Otsuka Pharmaceutical Co., Ltd. Medicament sustained-release particles and method for preparing the same
JP2008525313A (ja) * 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
WO2011037281A1 (ko) * 2009-09-23 2011-03-31 한국유나이티드제약 주식회사 용출률 향상과 부작용 발현이 최소화된 실로스타졸 서방정
CN101912374B (zh) * 2010-08-08 2016-01-20 浙江华海药业股份有限公司 喹硫平缓释片及其制备方法
EP2953454A1 (en) * 2013-02-08 2015-12-16 Agrofresh, Inc. Dry melt coating process and formulation for volatile compounds
PE20230105A1 (es) * 2020-03-02 2023-01-25 Gruenenthal Chemie Forma de dosificacion que proporciona liberacion prolongada de sal de acido fosforico de tapentadol
EP3875079A1 (en) * 2020-03-02 2021-09-08 Grünenthal GmbH Dosage form providing prolonged release of tapentadol phosphoric acid salt
KR20220123689A (ko) * 2020-03-11 2022-09-08 사와이세이야쿠 가부시키가이샤 과립 및 그것을 이용한 제제
KR102887463B1 (ko) * 2023-09-20 2025-11-19 한국소재융합연구원 자기치유성을 가지는 마스터배치 및 마스터배치를 이용한 자동차 내장재용 올레핀계 열가소성 탄성체 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62153213A (ja) * 1985-12-26 1987-07-08 Dai Ichi Seiyaku Co Ltd 腸溶性粒状物
JPH0647531B2 (ja) * 1986-02-06 1994-06-22 第一製薬株式会社 徐放性粒状物の製造法
JP2925346B2 (ja) * 1991-03-18 1999-07-28 田辺製薬株式会社 腸溶性製剤およびその製法
JP2538134B2 (ja) * 1991-04-08 1996-09-25 田辺製薬株式会社 徐放性製剤およびその製造法
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
ES2194863T3 (es) * 1992-11-30 2003-12-01 Kv Pharm Co Materiales farmaceuticos con enmascarado de sabor.
JPH07316042A (ja) * 1994-05-24 1995-12-05 Shionogi & Co Ltd マルチプルユニット型錠剤
KR100417746B1 (ko) * 1995-07-21 2004-05-31 다이이찌 세이야꾸 가부시기가이샤 입상제제의제조방법
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
JP2000169364A (ja) * 1998-09-30 2000-06-20 Taisho Pharmaceut Co Ltd 経口製剤用粒子
SI20244A (sl) * 1999-05-19 2000-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Granulacija v talini
JP3372242B2 (ja) * 1999-08-04 2003-01-27 沢井製薬株式会社 徐放性微粒子製剤及びその製造方法
JP3888064B2 (ja) 2000-01-27 2007-02-28 田辺製薬株式会社 徐放性製剤およびその製法

Also Published As

Publication number Publication date
HK1075414A1 (en) 2005-12-16
PT1484056E (pt) 2013-10-14
AU2003211243B2 (en) 2008-06-12
JPWO2003070223A1 (ja) 2005-06-09
TWI286481B (en) 2007-09-11
CN1638742A (zh) 2005-07-13
AU2003211243A1 (en) 2003-09-09
ES2429436T3 (es) 2013-11-14
TW200303221A (en) 2003-09-01
US20050106245A1 (en) 2005-05-19
AU2003211243B8 (en) 2008-11-06
JP4355925B2 (ja) 2009-11-04
US7927628B2 (en) 2011-04-19
MXPA04008137A (es) 2004-11-26
CN1301104C (zh) 2007-02-21
KR100913281B1 (ko) 2009-08-21
EP1484056B1 (en) 2013-08-14
WO2003070223A1 (en) 2003-08-28
CA2475441A1 (en) 2003-08-28
EP1484056A4 (en) 2009-06-10
KR20040084930A (ko) 2004-10-06
EP1484056A1 (en) 2004-12-08
CA2475441C (en) 2011-07-05

Similar Documents

Publication Publication Date Title
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK2508521T4 (da) Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1638999T3 (da) Sammensætninger og fremgangsmåder til øgning af knoglemineralisering
IS7520A (is) Pyrimidínonefnasambönd, samsetningar og aðferðir
DK1312922T3 (da) Nitritstabiliserende sammensætninger af tetrazoliumreagens og fremgangsmåder til deres anvendelse
DK1831154T3 (da) Fremstilling af pregabalin og relaterede forbindelser
DK2206517T3 (da) Immunpotentierende sammensætninger omfattende af anti-PD-L1-antistoffer
DK1575416T3 (da) Fremgangsmåder til diagnosticering af præeklampsi
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
DK1553929T3 (da) Sammensætning med kontrolleret frigivelse.
NO20025489L (no) Stabiliserte tetrasolium-fenasin-reagens-sammensetninger og fremgangsmåterfor deres anvendelse
DK1791791T3 (da) Fremgangsmåder og sammensætninger til behandling af vand
DK1856374T3 (da) Sammensætning og fremgangsmåde til fremstilling af et støttemiddel
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1457208T3 (da) Fremgangsmåde og farmaceutiske præparater til pålidelig opnåelse af acceptable serumtestosteronniveauer
DK1563069T3 (da) Sammensætninger og systemer til genregulering
DK1399133T3 (da) Langvarig frigörelsessammensætning omfattende mælkesyre-glycolsyre copolymer og fremgangsmåde til fremstilling af disse
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK1677949T3 (da) Antibelægningssammensætninger og fremgangsmåder til udvælgelse af disse
DK1509990T3 (da) Konfiguration og fremgangsmåde til beskyttelse af omformerorganer
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
DK1484056T3 (da) Sammensætninger med langsom frigivelse og fremgangsmåde til fremstilling af disse
DK1774566T3 (da) Sammensætninger til afgivelse af kviksölv og fremgangsmåde til fremstilling deraf
DK1589973T4 (da) Formulering og fremgangsmåder til behandling af thrombocytæmi